18 July 2021 - Aduhelm
< yesterday --
tomorrow >
The U.S. Food and Drug Administration approved the drug Aduhelm
surprisingly and despite, let us say, strong non-supporting data. Now
the turf war is on. Is it insider trading to be investigated by the
Securities and Exchange Commission, or straightforward bribery to be
investigated by the FBI? Or is it only a Trump time bomb going off, in
which case nobody cares?
clue:
The news dares mention no such thing, and bureaucrats speak in
euphemisms, but surely even reporters must think “Smells like
corruption.”
It looks like one investigation will be done by the FDA’s own
Inspector General.
give me a clue so sweet and true
copyright 2021, 2024 Jay J.P. Scott
<jay@satirist.org>